News Features Year in Review: SGLT2 Inhibition, Lipid-Lowering Make Waves in Clinical Cardiology in 2019 Todd Neale December 10, 2019
News Conference News AHA 2019 Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR Todd Neale November 17, 2019
News Daily News Women Bleed More Than Men After PCI, GLOBAL LEADERS Affirms Todd Neale November 07, 2019
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for October 2019 Todd Neale October 31, 2019
News Opinion Off Script TCT 2019 Off Script: The TWILIGHT of Aspirin? A Brief History of ASA’s Rise and Fall Kwan S. Lee September 29, 2019
News Conference News ESC 2019 Ticagrelor Risky in Diabetic Patients With Stable CAD: THEMIS Michael O'Riordan September 01, 2019
News Daily News Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI? Michael O'Riordan July 03, 2019
News Daily News Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues Todd Neale June 26, 2019
News Conference News SCAI 2019 Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology? Yael L. Maxwell May 30, 2019
News Daily News Initiative Helps Low-Resource Chinese Hospitals Provide Better ACS Care L.A. McKeown April 17, 2019
News Conference News ACC 2019 REDUCE-IT Subanalysis: Icosapent Ethyl Reduces Total and Recurrent CV Events Yael L. Maxwell March 22, 2019
News Conference News ACC 2019 ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend Shelley Wood March 11, 2019
News Conference News ISC 2019 Cilostazol-Based DAPT Safe, Effective in Patients at High Risk for Recurrent Stroke Todd Neale February 12, 2019